Overview
Location
United States, Massachusetts, Boston
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 31, 2024 | Akili to merge with Virtual Therapeutics in $34M deal | Photo: kupicoo/Getty Images Akili, the company behind video game-like prescription and over-the-counter digital therapeutics for individuals with ADHD, has signed a definitive merger agreement with mental health and fitness company Virtual ... |
| Sep 1, 2023 | Digital therapeutics could help with your insomnia, depression, and other concerns. But your insurer probably won't cover them. | About 40 digital-therapeutic apps have been cleared by the Food and Drug Administration since 2017. wagnerokasaki/Getty Images Redeem now Digital therapeutics can provide clinically proven ways to manage and track health conditions. One app... |
| Jun 26, 2023 | Prescription Digital Therapeutics Are Expanding What It Means To Treat Mental Health | More mental health treatment options are needed as demand continues to rise. |
| Aug 17, 2021 | Akili Enters Strategic Licensing Agreement With TALi, Extending Akili Portfolio And Industry Leadership In Prescription Digital Therapeutics For Cognitive Impairments | Through their shared focus on rigorous clinical validation and high-end user experience, the companies will continue to revolutionize the treatment of children with attention-deficit/hyperactivity disorder (ADHD) Akili will license TALi’s t... |
| Mar 2, 2021 | FDA: Orientation for Early Stage Startups | One of the most common topics YC Bio founders ask us about is the US Food and Drug Administration (FDA), and the broader regulatory environment. Obviously, with a topic this broad, there’s no way to give a single or simple answer; one could... |